A kind of long-acting injection microsphere containing entecavir and preparation method thereof
A technology of entecavir and microspheres, which is applied in the field of long-acting injection microspheres and its preparation, can solve the problems of aggravation of the disease, viral rebound, and inability to stop the drug casually.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] The present invention adopts S / W / O (water-in-oil-in-oil) process to prepare entecavir microspheres, and the specific preparation method is:
[0024] Weigh 4g of PLGA and dissolve it in 20mL of dichloromethane, add 0.4-0.8g of entecavir after jet crushing to it to obtain entecavir-PLGA suspension, ultrasonically disperse the suspension at high speed, specifically 6500-10000 / min ultrasonic Disperse for 3 to 5 minutes;
[0025] Quickly drop the entecavir-PLGA dispersion solution into 1% polyvinyl alcohol (PVA) aqueous solution, stir and emulsify at 1000r / min for 3-5min, quickly transfer to 0.1%PVA, magnetically stir for 4-6h to remove dichloromethane, 1000-1200 The washed balls were collected through a mesh sieve and freeze-dried to obtain the finished entecavir microspheres.
[0026] It is important for the application to add Entecavir to the PLGA solution after entecavir jet milling, jet milling can reduce the particle size of entecavir, specifically making the particle...
Embodiment 2- Embodiment 6
[0032] Embodiment 2-embodiment 6, its preparation method is the same as embodiment 1. The only difference lies in the type and viscosity of PLGA, see Table 1 for details.
[0033] The model and the viscosity of the PLGA of table 1 embodiment 1-6
[0034]
[0035] Note: In the PLGA model, 5050, 6535, and 8515 indicate that the lactic acid / glycolic acid (LA / GA) in the polymer material is 50:50, 65:35, and 85:15, respectively. A indicates that the polymer is terminated with a carboxyl group, and E indicates that Polymers are terminated with ester groups.
[0036] Determination of drug loading and encapsulation efficiency:
[0037] HPLC conditions: Chromatographic column: C18 column (200mm×4.6mm, 5μm), mobile phase: methanol: water = 20:80, detection wavelength: 254nm, flow rate: 1.0mL min -1 , column temperature: 40°C, injection volume: 100 μL.
[0038] Accurately weigh 10 mg of entecavir microspheres prepared in Example 1, add an appropriate amount of dichloromethane to d...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


